18.3 Percent of Physicians Reported PTSD During COVID-19 Pandemic
By Elana Gotkine HealthDay Reporter
THURSDAY, July 25, 2024 -- More than 18 percent of physicians reported posttraumatic stress disorder (PTSD) during the COVID-19 pandemic, according to a review and meta-analysis published online July 24 in JAMA Network Open.
Mihir Kamra, from McMaster University in Hamilton, Ontario, Canada, and colleagues examined the prevalence of PTSD among physicians during the COVID-19 pandemic and examined variations based on demographic and other variables in a systematic review and meta-analysis. Data were included from 57 studies with 28,965 participants in 25 countries.
The researchers observed an estimated pooled prevalence of 18.3 percent for PTSD. In 14 studies that reported sex, female physicians were more likely to develop PTSD (odds ratio, 1.93). Younger physicians reported less PTSD in the 10 studies reporting age. PTSD was most common among emergency department doctors in the 13 studies reporting specialty. Trainees were more likely to develop PTSD than attendings among the 16 studies reporting career stage (odds ratio, 1.33).
"The findings of this meta-analysis and systematic review suggest a pooled estimate of physician PTSD of 18 percent during the COVID-19 pandemic, a figure that is higher than PTSD in the general population or previously reported PTSD in physicians before the pandemic," the authors write. "The high prevalence of PTSD suggests that system level changes may be indicated to support physician health, which can include wellness supports and specific interventions to target and alleviate root causes."
Two authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2024
Further Support and Information on COVID-19
Read this next
GLP1RAs Tied to Greater Risk of Diabetic Retinopathy Progression Than SGLT2is
FRIDAY, July 26, 2024 -- In patients with diabetes and established diabetic retinopathy (DR), treatment with glucagon-like peptide 1 receptor agonists (GLP1RAs) is associated with...
Racial Disparities Identified for Time to Diagnosis of Huntington Disease
FRIDAY, July 26, 2024 -- Black individuals are diagnosed with Huntington disease (HD) at least one year later than White individuals, according to a study published online June 21...
Widespread Brain Structural Alterations Seen in Conduct Disorders
FRIDAY, July 26, 2024 -- There are widespread brain structural alterations apparent in conduct disorders, mostly in surface area, according to a study published in the August...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.